UNIGE document Scientific Article
previous document  unige:80787  next document
add to browser collection

Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus

Adam, René
de Gramont, Aimery
Figueras, Joan
Kokudo, Norihiro
Kunstlinger, Francis
Loyer, Evelyne
Poston, Graeme
Rougier, Philippe
show hidden authors show all authors [1 - 15]
Published in Cancer treatment reviews. 2015, vol. 41, no. 9, p. 729-741
Abstract An international panel of multidisciplinary experts convened to develop recommendations for managing patients with colorectal cancer (CRC) and synchronous liver metastases (CRCLM). A modified Delphi method was used. CRCLM is defined as liver metastases detected at or before diagnosis of the primary CRC. Early and late metachronous metastases are defined as those detected ⩽12months and >12months after surgery, respectively. To provide information on potential curability, use of high-quality contrast-enhanced computed tomography (CT) before chemotherapy is recommended. Magnetic resonance imaging is increasingly being used preoperatively to aid detection of subcentimetric metastases, and alongside CT in difficult situations. To evaluate operability, radiology should provide information on: nodule size and number, segmental localization and relationship with major vessels, response after neoadjuvant chemotherapy, non-tumoral liver condition and anticipated remnant liver volume. Pathological evaluation should assess response to preoperative chemotherapy for both the primary tumour and metastases, and provide information on the tumour, margin size and micrometastases. Although the treatment strategy depends on the clinical scenario, the consensus was for chemotherapy before surgery in most cases. When the primary CRC is asymptomatic, liver surgery may be performed first (reverse approach). When CRCLM are unresectable, the goal of preoperative chemotherapy is to downsize tumours to allow resection. Hepatic resection should not be denied to patients with stable disease after optimal chemotherapy, provided an adequate liver remnant with inflow and outflow preservation remains. All patients with synchronous CRCLM should be evaluated by a hepatobiliary multidisciplinary team.
PMID: 26417845
Full text
Article (Accepted version) (836 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Métastases du foie (657)
(ISO format)
ADAM, René et al. Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus. In: Cancer treatment reviews, 2015, vol. 41, n° 9, p. 729-741. doi: 10.1016/j.ctrv.2015.06.006 https://archive-ouverte.unige.ch/unige:80787

434 hits

0 download


Deposited on : 2016-02-22

Export document
Format :
Citation style :